| A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial (NCT07754175) | Kang Stem Biotech Co., Ltd. | 2026-07-20 |
| Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis (NCT05944627) | Kang Stem Biotech Co., Ltd. | 2023-07-06 |
| Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj (NCT04730024) | Kang Stem Biotech Co., Ltd. | 2022-03-27 |
| Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106) (NCT07582237) | Kang Stem Biotech Co., Ltd. | 2021-10-05 |
| Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) (NCT05004324) | Kang Stem Biotech Co., Ltd. | 2021-06-29 |
| Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis (NCT04725136) | Kang Stem Biotech Co., Ltd. | 2021-01-27 |
| Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202) (NCT04134169) | Kang Stem Biotech Co., Ltd. | 2019-10-02 |
| Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients (NCT04087863) | Kang Stem Biotech Co., Ltd. | 2019-08-29 |
| Evalution the Safety and Efficacy in Atopic Dermatitis Patients (NCT03962387) | Kang Stem Biotech Co., Ltd. | 2019-04-05 |
| Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis (NCT03618784) | Kang Stem Biotech Co., Ltd. | 2018-07-11 |
| Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD) (NCT03269773) | Kang Stem Biotech Co., Ltd. | 2018-04-25 |
| Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis (NCT02918123) | Kang Stem Biotech Co., Ltd. | 2018-01-17 |